Bangladesh Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Bangladesh Pharmaceuticals and Healthcare Report

Bangladesh Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Bangladesh Pharmaceuticals and Healthcare Report
Published Oct 01, 2016
89 pages — Published Oct 01, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In June ----, the World Bank announced that it has approved USD---mn in additional funding to help improve Bangladesh s health system. This brings the total support from the World Bank on health projects to USD---mn. ...This brings the total support from the World Bank on health projects to USD---mn. The support is expected to help the government sustain and improve immunisation coverage, improve deliveries for pregnant women at public facilities and tackle multi-drug resistant tuberculosis. In July ----, Bangladesh s Export Promotion Bureau noted that the country exported USD--mn of medicines for the fiscal year -------. ...In August ----, the High Court in Bangladesh ordered -- drugmakers to stop manufacturing medicines following revelations that the firms had ignored a ban imposed in June. Under the original order, -- were told to cease manufacturing and firms will now have till August -- ---- to stop producing the products.

...In Q--- Bangladesh s Risk/Reward Index (RRI) score remains unchanged from last quarter at --.- out of ---. Bangladesh also retains its ranking position in BMI s RRI matrix, standing as the --th most attractive market to pharmaceutical investors out of -- markets in the Asia Pacific region. ...In Q--- Bangladesh s Risk/Reward Index (RRI) score remains unchanged from last quarter at --.- out of ---. Bangladesh also retains its ranking position in BMI s RRI matrix, standing as the --th most attractive market to pharmaceutical investors out of -- markets in the Asia Pacific region. Bangladesh s score is driven by a large pharmaceutical market (market expenditure score of --.- out of --) and rapid drug market expansion (sector value growth score of -.- out of --), but dragged down by low levels of drug spending per capita (spending per capita score of -.- out of --) and limited intellectual property protection (patent respect score of -.- out of -). ...Bangladesh also retains its ranking position in BMI s RRI matrix, standing as the --th most attractive market to pharmaceutical investors out of -- markets in the Asia Pacific region. Bangladesh s score is driven by a large pharmaceutical market (market expenditure score of --.- out of --) and rapid drug market expansion (sector value growth score of -.- out of --), but dragged down by low levels of drug spending per capita (spending per capita score of -.- out of --) and limited intellectual property protection (patent respect score of -.- out of -).

...Many domestic manufacturers lack full-spectrum generic drug manufacturing capabilities. Prices are kept low, with the government reluctant to approve price increases, despite changes in currency fluctuations and the rising cost of raw materials. ...

  
Source:
Document ID
1758-485X
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Bangladesh Pharmaceuticals and Healthcare Report" Oct 01, 2016. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Bangladesh-Pharmaceuticals-and-Healthcare-Report-2026-622>
  
APA:
Business Monitor International - Industry Reports. (2016). Bangladesh Pharmaceuticals and Healthcare Report Oct 01, 2016. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Bangladesh-Pharmaceuticals-and-Healthcare-Report-2026-622>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.